Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-051624
Filing Date
2017-09-06
Accepted
2017-09-06 16:29:38
Documents
1
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7860
  Complete submission text file 0001209191-17-051624.txt   9249
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Issuer) CIK: 0001435049 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Lew Jennifer (Reporting) CIK: 0001465994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37345 | Film No.: 171071637